96
Views
5
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Favourable outcomes in children with diffuse large B-cell lymphoma treated by a short-term ALL-like regimen: A report on the NHL960 study from the Japanese Childhood Cancer and Leukemia Study Group

, , , , , , , , , & show all
Pages 734-739 | Received 21 Jul 2007, Accepted 05 Dec 2007, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Naoto Fujita, Ryoji Kobayashi, Tetsuya Takimoto, Atsuko Nakagawa, Kazuhiro Ueda & Keizo Horibe. (2011) Results of the Japan Association of Childhood Leukemia Study (JACLS) NHL-98 protocol for the treatment of B-cell non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia in childhood. Leukemia & Lymphoma 52:2, pages 223-229.
Read now

Articles from other publishers (4)

Ryoji Kobayashi, Shosuke Sunami, Tetsuo Mitsui, Atsuko Nakazawa, Yuhki Koga, Takeshi Mori, Fumiko Tanaka, Jun-ichi Ueyama, Tomoo Osumi, Reiji Fukano, Kentaro Ohki, Masahiro Sekimizu & Tetsuya Mori. (2015) Treatment of pediatric lymphoma in Japan: Current status and plans for the future. Pediatrics International 57:4, pages 523-534.
Crossref
Masahito Tsurusawa, Tetsuya Mori, Akira Kikuchi, Tetsuo Mitsui, Shosuke Sunami, Ryoji Kobayashi, Tetsuya Takimoto, Akiko Saito, Tomoyuki Watanabe, Junichiro Fujimoto, Atsuko Nakazawa, Kouichi Ohshima & Keizo Horibe. (2014) Improved treatment results of children with B-cell non-Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 study. Pediatric Blood & Cancer 61:7, pages 1215-1221.
Crossref
Yasuto Shimomura, Reizo Baba, Arata Watanabe, Yasuo Horikoshi, Keiko Asami, Nobuyuki Hyakuna, Asayuki Iwai, Takeshi Matsushita, Kazutaka Yamaji, Toshinori Hori & Masahito Tsurusawa. (2011) Assessment of late cardiotoxicity of pirarubicin (THP) in children with acute lymphoblastic leukemia. Pediatric Blood & Cancer 57:3, pages 461-466.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:4, pages 253-260.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.